| Date | Company Name | Action | Current
Price | Price
Target | Rating | Impact on
Share Price |
|---|
| 8/15/2023 | GLTO Galecto | Downgrade | $1.00 | | Outperform ➝ Market Perform | Low |
| 8/15/2023 | VIRX Viracta Therapeutics | Lower Price Target | $1.00 | $10.00 ➝ $5.00 | Outperform ➝ Outperform | Low |
| 8/15/2023 | CNTA Centessa Pharmaceuticals | Boost Price Target | $10.00 | $6.00 ➝ $11.00 | Outperform ➝ Outperform | Low |
| 8/15/2023 | DSGN Design Therapeutics | Downgrade | $4.00 | $6.00 | Outperform ➝ Market Perform | Low |
| 8/15/2023 | TSBX Turnstone Biologics | Initiated Coverage | $3.00 | | Market Perform | Low |
| 8/15/2023 | CYTK Cytokinetics | Initiated Coverage | $66.00 | $58.00 | Outperform | Low |
| 8/8/2023 | RLAY Relay Therapeutics | Initiated Coverage | $6.00 | | Outperform | Low |
| 8/8/2023 | EXEL Exelixis | Initiated Coverage | $23.00 | $18.00 | Market Perform | Low |
| 8/8/2023 | IDYA IDEAYA Biosciences | Initiated Coverage | $38.00 | $33.00 | Outperform | Low |
| 8/8/2023 | QTRX Quanterix | Upgrade | $16.00 | $30.00 | Market Perform ➝ Outperform | Low |
| 8/8/2023 | NUVL Nuvalent | Initiated Coverage | $64.00 | $42.00 | Market Perform | Low |
| 8/4/2023 | NVCR NovoCure | Initiated Coverage | $12.00 | $51.00 | Outperform | Low |
| 7/26/2023 | BLTE Belite Bio | Initiated Coverage | $34.00 | $25.00 | Outperform | Low |
| 7/24/2023 | NBIX Neurocrine Biosciences | Upgrade | $134.00 | $115.00 ➝ $125.00 | Market Perform ➝ Outperform | Low |
| 7/13/2023 | CYRX Cryoport | Downgrade | $16.00 | $30.00 ➝ $10.00 | Outperform ➝ Market Perform | Low |
| 7/10/2023 | BMY Bristol-Myers Squibb | Initiated Coverage | $49.00 | $66.00 | Market Perform | Low |
| 6/26/2023 | MLTX MoonLake Immunotherapeutics | Boost Price Target | $41.00 | $28.00 ➝ $56.00 | | Low |
| 6/20/2023 | EHAB Enhabit | Initiated Coverage | $10.00 | $10.00 | Underperform | Low |
| 6/14/2023 | PEPG PepGen | Lower Price Target | $11.00 | $33.00 ➝ $28.00 | | Low |
| 6/14/2023 | UNH UnitedHealth Group | Lower Price Target | $491.00 | $625.00 ➝ $560.00 | | Low |
| 6/12/2023 | OCS Oculis | Initiated Coverage | $12.00 | | Outperform | Low |
| 6/8/2023 | CVAC CureVac | Initiated Coverage | $3.00 | $13.00 | Outperform | Low |
| 6/5/2023 | CSTL Castle Biosciences | Lower Price Target | $20.00 | $50.00 ➝ $35.00 | | Low |
| 6/5/2023 | BPMC Blueprint Medicines | Downgrade | $91.00 | $48.00 ➝ $43.00 | Market Perform ➝ Underperform | Low |
| 5/30/2023 | ELEV Elevation Oncology | Upgrade | $4.00 | $5.00 ➝ $8.00 | Market Perform ➝ Outperform | Low |
| 5/26/2023 | UHS Universal Health Services | Upgrade | $161.00 | $147.00 ➝ $170.00 | Market Perform ➝ Outperform | Low |
| 5/24/2023 | A Agilent Technologies | Lower Price Target | $134.00 | $170.00 ➝ $145.00 | Outperform | Low |
| 5/23/2023 | VECT VectivBio | Downgrade | $17.00 | | Outperform ➝ Market Perform | Low |
| 5/12/2023 | ARWR Arrowhead Pharmaceuticals | Downgrade | $24.00 | $40.00 | Outperform ➝ Market Perform | Low |
| 5/5/2023 | ABCL AbCellera Biologics | Lower Price Target | $4.00 | $16.00 ➝ $15.00 | | Low |
| 5/5/2023 | ALHC Alignment Healthcare | Lower Price Target | $5.00 | $24.00 ➝ $12.00 | | Low |
| 5/5/2023 | VIR Vir Biotechnology | Lower Price Target | $8.00 | $43.00 ➝ $42.00 | | Low |
| 5/5/2023 | AGIO Agios Pharmaceuticals | Lower Price Target | $30.00 | $37.00 ➝ $34.00 | | Low |
| 5/5/2023 | PRVA Privia Health Group | Boost Price Target | $18.00 | $39.00 ➝ $40.00 | | Low |
| 5/5/2023 | AMED Amedisys | Lower Price Target | $91.00 | $96.00 ➝ $81.00 | | Low |
| 5/5/2023 | LNTH Lantheus | Boost Price Target | $63.00 | $120.00 ➝ $127.00 | | Low |
| 5/5/2023 | REGN Regeneron Pharmaceuticals | Lower Price Target | $900.00 | $976.00 ➝ $895.00 | | Low |
| 5/1/2023 | DHR Danaher | Initiated Coverage | $236.00 | $300.00 | Outperform | Low |
| 5/1/2023 | LLY Eli Lilly and Company | Boost Price Target | $731.00 | $410.00 ➝ $458.00 | | Low |
| 4/27/2023 | HUM Humana | Lower Price Target | $325.00 | $640.00 ➝ $600.00 | | Low |
| 4/26/2023 | ALVR AlloVir | Boost Price Target | $1.00 | $16.00 ➝ $19.00 | | Low |
| 4/24/2023 | PRTA Prothena | Initiated Coverage | $21.00 | $80.00 | Outperform | Low |
| 4/17/2023 | MRUS Merus | Boost Price Target | $40.00 | $35.00 ➝ $48.00 | Outperform | Low |
| 4/13/2023 | FDMT 4D Molecular Therapeutics | Lower Price Target | $26.00 | $14.00 ➝ $13.00 | Market Perform | Low |
| 4/13/2023 | BBIO BridgeBio Pharma | Boost Price Target | $25.00 | $25.00 ➝ $27.00 | Outperform | Low |
| 4/12/2023 | ARWR Arrowhead Pharmaceuticals | Upgrade | $24.00 | $21.00 ➝ $35.00 | Market Perform ➝ Outperform | Low |
| 4/11/2023 | CORT Corcept Therapeutics | Initiated Coverage | $22.00 | $25.00 | Market Perform | Low |
| 4/10/2023 | IPHA Innate Pharma | Boost Price Target | $2.00 | $9.00 ➝ $10.00 | | Low |
| 3/30/2023 | ACLX Arcellx | Boost Price Target | $52.00 | $35.00 ➝ $39.00 | | Low |
| 3/27/2023 | REGN Regeneron Pharmaceuticals | Upgrade | $900.00 | $834.00 ➝ $976.00 | Market Perform ➝ Outperform | Low |
| 3/24/2023 | INCY Incyte | Upgrade | $52.00 | $61.00 | Underperform ➝ Market Perform | Low |
| 3/17/2023 | CNTA Centessa Pharmaceuticals | Initiated Coverage | $10.00 | $6.00 | Outperform | Low |
| 3/17/2023 | PTCT PTC Therapeutics | Initiated Coverage | $26.00 | $48.00 | Market Perform | Low |
| 3/16/2023 | HALO Halozyme Therapeutics | Downgrade | $39.00 | $42.00 | Outperform ➝ Market Perform | Low |
| 3/10/2023 | FULC Fulcrum Therapeutics | Lower Price Target | $7.00 | $18.00 ➝ $10.00 | | Low |
| 3/8/2023 | MORF Morphic | Boost Price Target | $28.00 | $45.00 ➝ $56.00 | | Low |
| 3/3/2023 | ARGX argenx | Boost Price Target | $369.00 | $430.00 ➝ $435.00 | | Low |
| 3/1/2023 | MDRX Veradigm | Lower Price Target | $8.00 | $24.00 ➝ $17.00 | | Low |
| 3/1/2023 | AHCO AdaptHealth | Lower Price Target | $10.00 | $30.00 ➝ $23.00 | | Low |
| 2/28/2023 | GPCR Structure Therapeutics | Initiated Coverage | $36.00 | $33.00 | Outperform | Low |
| 2/28/2023 | IRON Disc Medicine | Initiated Coverage | $27.00 | $36.00 | Outperform | Low |
| 2/24/2023 | NKTR Nektar Therapeutics | Lower Price Target | $1.00 | $5.00 ➝ $3.00 | | N/A |
| 2/24/2023 | BPMC Blueprint Medicines | Lower Price Target | $91.00 | $45.00 ➝ $38.00 | | Low |
| 2/24/2023 | MRNA Moderna | Downgrade | $104.00 | $111.00 ➝ $93.00 | Market Perform ➝ Underperform | Low |
| 2/23/2023 | TDOC Teladoc Health | Upgrade | $13.00 | $34.00 | Market Perform ➝ Outperform | Low |
| 2/23/2023 | IONS Ionis Pharmaceuticals | Lower Price Target | $41.00 | $34.00 ➝ $27.00 | | Low |
| 2/10/2023 | ABBV AbbVie | Upgrade | $168.00 | $135.00 ➝ $153.00 | Underperform ➝ Market Perform | Low |
| 2/8/2023 | CI The Cigna Group | Lower Price Target | $353.00 | $335.00 ➝ $309.00 | | Low |
| 2/8/2023 | VRTX Vertex Pharmaceuticals | Lower Price Target | $400.00 | $374.00 ➝ $365.00 | | Low |
| 2/2/2023 | META Meta Platforms | Boost Price Target | $482.00 | $220.00 ➝ $255.00 | Outperform | Low |
| 2/2/2023 | AMGN Amgen | Lower Price Target | $272.00 | $282.00 ➝ $267.00 | | Low |
| 1/30/2023 | DNLI Denali Therapeutics | Initiated Coverage | $16.00 | $50.00 | Outperform | Low |
| 1/24/2023 | BHVN Biohaven | Initiated Coverage | $38.00 | $24.00 | Outperform | Low |
